123 related articles for article (PubMed ID: 9836286)
1. Seasonal variations in blood clotting time in mice treated with an anticoagulant aminoestrogen.
Rubio-Póo C; Silva G; Jaimez R; Lemini C
Proc West Pharmacol Soc; 1998; 41():179-82. PubMed ID: 9836286
[No Abstract] [Full Text] [Related]
2. Effects on blood clotting time of 17 beta-estradiol and 17 beta-aminoestrogens in rats and mice.
Jaimez R; Rubio-Póo C; Lemini C
Proc West Pharmacol Soc; 2001; 44():163-6. PubMed ID: 11793970
[No Abstract] [Full Text] [Related]
3. The effects of five new 17 beta-amino-estrogens, buame, endiame, etolame, picae, and procame on blood clotting time.
Mandoki JJ; Rubio-Póo C; Lemini C; De la Peña A; Fernández JM; García-Mondragón J; Zavala E; Silva G; Mendoza-Patiño N
Proc West Pharmacol Soc; 1991; 34():99-106. PubMed ID: 1788352
[No Abstract] [Full Text] [Related]
4. Contrasting effects of estradiol and 17 beta-aminoestrogens on blood clotting time in rats and mice.
Lemini C; Franco Y; Avila ME; Jaimez R
Eur J Pharmacol; 2005 Mar; 510(3):229-33. PubMed ID: 15763247
[TBL] [Abstract][Full Text] [Related]
5. Standardization of rat blood clotting tests with reagents used for humans.
García-Manzano A; González-Llaven J; Lemini C; Rubio-Póo C
Proc West Pharmacol Soc; 2001; 44():153-5. PubMed ID: 11793967
[No Abstract] [Full Text] [Related]
6. Comparison of the time course of anticoagulant and estrogenic effects of prolame, butolame, pentolame and hexolame, a homologous series of 17 beta-amino estrogens.
Rubio-Póo C; Lemini C; Silva G; García-Mondragón J; Zavala E; Castro D; Mendoza-Patiño N; Mandoki JJ
Proc West Pharmacol Soc; 1993; 36():143-7. PubMed ID: 8378368
[No Abstract] [Full Text] [Related]
7. The dual effects of estrogens on blood clotting time.
Mandoki JJ; Zavala E; Silva G; Mendoza-Patiño N; Rubio-Póo C; Medina-Martínez S; Domínguez-Escoto P
Proc West Pharmacol Soc; 1983; 26():45-8. PubMed ID: 6310634
[No Abstract] [Full Text] [Related]
8. Coagulation and fibrinolytic studies on 17-beta-estradiol and synthetic estrogens.
Astedt B
Acta Obstet Gynecol Scand Suppl; 1977; 65():45-8. PubMed ID: 269625
[No Abstract] [Full Text] [Related]
9. In vivo profile of the anticoagulant effect of 17ß-amino-1,3,5(10)estratrien-3-ol.
Lemini C; Rubio-Póo C; Franco Y; Jaimez R; Avila ME; Medina M; Lemus AE
Eur J Pharmacol; 2013 Jan; 700(1-3):210-6. PubMed ID: 23305838
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal treatment of the menopause and vascular pathology].
Rozenbaum H
J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
[No Abstract] [Full Text] [Related]
11. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
12. Prodiame: a new estrogen with sustained anticoagulant effect.
Rubio-Póo C; Mandoki JJ; Jayme V; Mendoza-Patiño N; Alvarado C; Silva G; Zavala E; Fernández-González JM; Rubio-Arroyo M
Proc West Pharmacol Soc; 1983; 26():111-3. PubMed ID: 6889323
[No Abstract] [Full Text] [Related]
13. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
[TBL] [Abstract][Full Text] [Related]
14. [Effects of tanshinone II-A sulfonate on thrombus formation, platelet and blood coagulation in rats and mice].
Li CZ; Yang SC; Zhao FD
Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):39-42. PubMed ID: 6232819
[No Abstract] [Full Text] [Related]
15. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].
Lemini C; Rubio-Póo C; Silva G; García-Mondragón J; Zavala E; Mendoza-Patiño N; Castro D; Cruz-Almanza R; Mandoki JJ
Steroids; 1993 Oct; 58(10):457-61. PubMed ID: 8256254
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of hemostasis].
Laporte J
Actual Pharmacol (Paris); 1973; 26(0):183-207. PubMed ID: 4793291
[No Abstract] [Full Text] [Related]
18. [Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
Lutsik LA
Sov Med; 1981; (2):52-5. PubMed ID: 7244809
[TBL] [Abstract][Full Text] [Related]
19. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
Carlsson SC; Schulman S
Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
[TBL] [Abstract][Full Text] [Related]
20. The action on blood clotting of different lipoid fractions of beef brain. (Methods of fractionization and chromatographic isolation procedure of a phospholipid anticoagulant).
Kahn MJ; Hans M; Bourgain RH
Thromb Diath Haemorrh; 1965 Nov; 14(3-4):445-53. PubMed ID: 5893638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
